Jobs / United States / Regeneron Pharmaceuticals INC

Regeneron Pharmaceuticals INC

Senior Pharmacokineticist, Translational Pharmacokinetics/Pharmacodynamics

TARRYTOWN Posted today

Apply on employer site ↗ Tailor my CV first Source: Company careers site

Optional: we can tailor a CV and cover letter for this job from your real experience first (the first one is free).

Sponsorship verdict

Sponsorship possible

One solid signal, not two. Worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
  • Confirmed live todayWhen a source last listed this job as open.
Details and sources
Employer is on a government sponsor record
The US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
No salary bar for this route
H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.

About the role

Build Our Future Together We are looking for a Senior Pharmacokineticist that will support Pharmacokinetics and Translational Pharmacokinetics/Pharmacodynamics requirements for Discovery and ND-stage project teams. Efforts include providing input/oversight and direction to early preclinical/nonclinical in vivo studies, interfacing with Therapeutic Focus Area scientific staff performing the preclinical studies and directing/managing non-clinical Pharmacokinetics studies. Preparing and presenting the analyses to internal project teams and senior management, and writing summary reports and documents to support regulatory filings.   When & where: • Work Location: Tarrytown, NY • Work model/flexibility: 4 days per week onsite Discover your role: • Serve on Discovery-stage project teams as a subject matter authority for Translational Pharmacokinetics / Pharmacodynamics, providing input regarding the design of discovery and preclinical PK and/or pharmacology studies. • Collaborate optimally with various groups within Regeneron, including Therapeutic Proteins, Therapeutic Function Areas, Assay Development group, Precision Medicine, Preclinical Operations, Toxicology and TPK/PD management to develop a PK strategy for each project and then delivering the required output. • Effectively communicate project team queries, requests and expectations (i.e. timing and results) from the Project Teams to management. • Conduct and report PK and PKUPD analyses using data derived from preclinical (nonclinical) studies. • Work in close association with the Toxicology, Pathology, Clinical Pharmacology, Quantitative Pharmacology (modeling & simulation) and the Translational Modeling groups within the Drug Safety and Pharmacometrics Department, to deliver the required data and study reports / regulatory documents to support project progression. • Maintain an up-to-date knowledge of the relevant scientific literature as well as regulatory guidance and best practices as they pertain to TPK/PD. This role requires: • PhD in Pharmacology, Pharmacokinetics, Biology/Molecular Biology, or Biochemistry with more than 5+ years of relevant experience in biotech or pharma. • Theoretical and applied understanding of PK and PD to interpret the pharmacology and biology of therapeutic proteins. Experience with other modalities such as siRNA, CRISPR-based therapeutics, and cell therapies is highly beneficial. • Proven ability to plan, coordinate, lead PK and/or PK/PD studies, and analyze related data. • Familiarity with PK/PD (e.g., WinNonLin), data visualization and AI software and experience writing scientific reports and regulatory summaries. Does this sound like you? Apply now to take your first step towards living the Regeneron Way! We are committed to building a workplace with an inclusive culture. Regeneron is an equal opportunity employer and all  qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other characteristic protected under applicable law. Where required, we will provide reasonable accommodation to applicants with known disabilities or chronic illnesses during the recruitment process, unless such accommodation would impose undue hardship.   Where necessary, we disclose salary ranges for roles in all countries in which we operate.  The final offer will be determined within the relevant range based on the country of employ

Apply on employer site ↗